ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Markman on Gynecologic Cancer Molecular Testing

Maurie Markman, MD
Published: Monday, Nov 04, 2013

Maurie Markman, MD, senior vice president for Clinical Affairs and National Director for Medical Oncology, Cancer Treatment Centers of America, Eastern Regional Medical Center, discusses the role of molecular testing in gynecologic cancers.

The role of molecular testing in gynecologic cancers is in its infancy. Markman believes that it is reasonable to use molecular testing on a patient who has failed standard therapy in order to provide a treatment option that was not previously considered.

In the future, Markman says, there will be drugs that are approved by the FDA for purposes not specifically related to gynecologic cancers. These agents would show value in gynecologic cancers because of molecular testing. Markman says that though this is a complicated area, it is evolving and represents the future in the disease.

Maurie Markman, MD, senior vice president for Clinical Affairs and National Director for Medical Oncology, Cancer Treatment Centers of America, Eastern Regional Medical Center, discusses the role of molecular testing in gynecologic cancers.

The role of molecular testing in gynecologic cancers is in its infancy. Markman believes that it is reasonable to use molecular testing on a patient who has failed standard therapy in order to provide a treatment option that was not previously considered.

In the future, Markman says, there will be drugs that are approved by the FDA for purposes not specifically related to gynecologic cancers. These agents would show value in gynecologic cancers because of molecular testing. Markman says that though this is a complicated area, it is evolving and represents the future in the disease.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x